New data presented at AHS 2022 indicate that prevalence of migraine in the USA has been stable while the proportion of people with moderate or severe MIDAS scores has nearly doubled, from 22% in 2005 to 42.4% in 2018.
Researchers from the Jefferson Headache Center, Indiana University, Montefiore Medical Center, Vedanta Research, and the Albert Einstein College of Medicine conducted a systematic review of US studies to investigate the prevalence and/or burden of migraine, episodic migraine (EM) or chronic migraine (CM).